Lockerman Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-526
Closed -$255K 120
2025
Q3
$255K Sell
526
-3
-0.6% -$1.4K 0.32% 103
2025
Q2
$214K Buy
529
+3
+0.6% +$1.25K 0.29% 117
2025
Q1
$262K Hold
526
0.4% 87
2024
Q4
$274K Sell
526
-3
-0.6% -$1.65K 0.47% 74
2024
Q3
$327K Buy
529
+57
+12% +$33.7K 0.55% 60
2024
Q2
$261K Buy
472
+99
+27% +$56.7K 0.47% 77
2024
Q1
$217K Buy
+373
New +$209K 0.41% 97
2023
Q4
Sell
-400
Closed -$202K 90
2023
Q3
$202K Buy
400
+9
+2% +$4.8K 0.54% 77
2023
Q2
$204K Sell
391
-6
-2% -$3.24K 0.57% 67
2023
Q1
$229K Sell
397
-7
-2% -$3.94K 0.63% 62
2022
Q4
$222K Buy
+404
New +$214K 0.65% 62

Other funds holding TMO

Lockerman Financial Group's TMO Position: Q4 2025 in Review

Lockerman Financial Group sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 526 shares — an estimated $255K sold.

Lockerman Financial Group first reported a position in TMO in Q4 2022 and held it in 11 quarters. The position peaked at $327K in Q3 2024. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Lockerman Financial Group reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Lockerman Financial Group sold 526 Thermo Fisher Scientific shares in Q4 2025, an estimated $255K.
  • Lockerman Financial Group first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 11 quarters.
  • Lockerman Financial Group's Thermo Fisher Scientific position peaked at $327K in Q3 2024.
  • 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Lockerman Financial Group's 13F filing for Q4 2025, filed 21 Jan 2026.